Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.08% | 132.19 | 0.0% | $1230.60m | |
| OCGN | Ocugen, Inc. | -2.56% | 8.74 | 0.0% | $941.39m | |
| NVAX | Novavax, Inc. | 10.59% | 174.84 | 92.9% | $613.91m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.71% | 461.57 | 2.7% | $556.12m | |
| AMGN | Amgen, Inc. | 2.62% | 227.73 | 1.3% | $540.12m | |
| GILD | Gilead Sciences, Inc. | 2.20% | 64.62 | 1.0% | $516.91m | |
| ILMN | Illumina, Inc. | -0.19% | 398.85 | 3.5% | $484.87m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.02% | 211.98 | 1.9% | $458.30m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.11% | 150.10 | 2.0% | $339.49m | |
| BIIB | Biogen, Inc. | 2.71% | 270.71 | 1.7% | $305.38m | |
| CRSP | CRISPR Therapeutics AG | -0.73% | 114.65 | 0.6% | $304.78m | |
| BNGO | BioNano Genomics, Inc. | 3.62% | 7.15 | 0.0% | $275.81m | |
| EXAS | EXACT Sciences Corp. | 0.51% | 121.64 | 18.4% | $251.13m | |
| SGEN | Seagen Inc. | 2.68% | 149.35 | 5.8% | $225.25m | |
| PACB | Pacific Biosciences of California, Inc. | 1.70% | 29.27 | 7.2% | $176.23m |
Company Profile
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.